Rheumatology

Your Article Summary

See Latest Articles

The epidemiology of Takayasu arteritis in the UK
Rheumatology, 06/25/09

Watts R et al. - Population-based study of the epidemiology of Takayasu arteritis (TAK) reports that the annual incidence and prevalence are consistent with previous studies.

• Aim was to determine the annual incidence of TAK in the UK using the UKGPRD and in a well-defined hospital population (NORVASC)
• Pts in the UKGPRD with a first diagnosis of TAK during 2000–05 were identified
• Annual incidence was calculated as the number of incident cases divided by total person-years

• 14 subjects (13 females) were identified with a first diagnosis of TAK during 2000–05 in the UKGPRD
• Median age was 51.0 yrs
• Overall annual incidence of TAK was 0.8/million
• Incidence was stable throughout the study period
• Mean prevalence of TAK was 4.7/million
• There were 6 pts (5 females) aged <40 yrs presenting in 2000–05 with TAK
• The annual incidence in those aged <40 yrs was 0.3/million
• In the NORVASC population, 1 case was identified (0.4/million/year) with 3 prevalent cases (7.1/million)

Today in Vasculitic Syndromes...keeping you current

Receive free subspecialty "5-minute updates" via email

One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behçets disease refractory to standard immunosuppressive drugs
Rheumatology International, 10/30/09

Vasculitis in Children and Adolescents: Clinical Presentation, Etiopathogenesis, and Treatment
Pediatric Drugs, 11/11/09

Update in paediatric vasculitis
Best Practice & Research: Clinical Rheumatology, 10/27/09

See All of Vasculitic Syndromes